Methods for culturing mammalian cells
By adding nisin tricarboxylic acid or its salt in the seed culture stage, the problems of cell viability and lactic acid accumulation in the later stage of CHO cell culture were solved, and the cell viability and product expression were significantly improved, and lactic acid accumulation was reduced. It is suitable for improving biopharmaceuticals protein production.
Patent Information
- Application Number
- CN202111186645.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-12
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2041-10-12
AI Technical Summary
The prior art is difficult to effectively improve the cell viability in the later stage of CHO cell culture and reduce lactic acid accumulation, resulting in protein expression and quality problems. The existing methods are not very operable or have adverse effects on cell growth.
Adding nisin tricarboxylic acid or its salt as an additive to the basal culture medium during the seed culture stage will significantly improve the growth performance and product expression of cells in the production and culture stage, reduce lactic acid accumulation, and improve cell viability and viable cell density.
The addition of nisin tricarboxylic acid or its salt in the seed culture stage significantly improves the cell viability and live cell density in the production and culture stage, reduces lactic acid accumulation, enhances product expression, and is easy to purify and low-cost.
Smart Images

Figure CN113862217B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of mammalian cell culture, and in particular to a method for improving the growth, metabolism and product expression of mammalian host cells. Background Art
[0002] Producing genetically engineered proteins through mammalian cell culture is a common method for obtaining therapeutic proteins such as monoclonal antibodies. Among them, CHO cells (Chinese hamster ovary cells) are currently the most important and most commonly used expression system. Compared with other expression systems, it has the following advantages: continuous cell line, rapid growth, uniform cell type, can be passaged for more than 100 generations, and is convenient for larger-scale production; it belongs to fibroblasts, which are non-secreting cells and rarely secrete CHO endogenous proteins, so it is very beneficial for the separation and purification of target proteins; it has good expression and modification capabilities, such as glycosylation function, and is an ideal host for expressing complex biomacromolecules. So far, the important recombinant proteins and their expression production approved mainly come from the CHO cell expression system.
[0003] Improving the performance of CHO cell culture, such as increasing cell culture viability, improving lactic acid metabolism, and increasing the target protein yield and quality, has always been a key goal in the biopharmaceutical field. In the later stage of cell culture, cells usually enter a state of death, which may be related to the various stresses faced by cells, such as the accumulation of toxic metabolic byproducts, limited space, and nutrient deficiency, which cause cells to enter a state of death in the later stage. Maintaining a good cell viability helps to increase protein yield and improve protein quality. In addition, lactic acid is the main metabolic byproduct in the cell culture process. CHO cells usually accumulate lactic acid rapidly during the metabolically active logarithmic growth phase. Some cell lines can metabolize and consume this lactic acid, but some cell lines lack this ability. The accumulation of a large amount of lactic acid will seriously affect protein expression and protein quality. The accumulation of lactic acid will cause the pH of the culture system to decrease and the cells to acidify. The alkali solution added to maintain a certain pH often increases the osmotic pressure of the system, thereby affecting the normal growth and metabolism of cells.
[0004] In order to improve protein production and quality and obtain a stable culture process, cell culture researchers are committed to improving the viability of cells in the later stages of culture and reducing the accumulation of lactic acid. The methods used in the prior art to improve the viability of cells in the later stages include: lowering the culture temperature, optimizing the feeding strategy, replacing the culture medium, etc., but these methods may result in reduced production or less than ideal results. The methods used in the prior art to reduce lactic acid accumulation include: knocking out related genes, such as knocking out the lactate dehydrogenase (LDH) gene; replacing glucose as a carbon source with slowly metabolized sugars, such as galactose, fucose, and maltose; reducing the concentration of glucose; or adding copper ions (Cu 2+ ). However, these methods are either not very practical or have adverse effects on cell growth and protein quality. Therefore, the current cell culture field has a special demand for methods or additives to improve the growth and production performance of cell culture in the later stage and reduce lactic acid accumulation.
[0005] Aurintricarboxylic acid (ATA), molecular formula: C 22 H 14 O9. Aurintricarboxylic acid ammonium salt (also known as Aluminon, Ammoniumaurintricarboxylate, ATA ammonium), molecular formula is C 22 H 14 O9·3NH3. Although ATA is mentioned in other documents and patents related to culture medium formulations, its usage, effects and principles of biological function are significantly different from those of the present invention. The application of ATA in the literature or patents disclosed in the prior art is as follows: ATA is added to the culture medium as a substitute for insulin, IGF-1 or transferrin, and is added to the culture medium in the production stage, not in the culture medium in the seed stage. For example: "Zhanyou yun, Journal of bioscience and bioengineering, Vol.95, no.2, 124127.2003" ATA is used as Fe 2+ Chelating agent, reducing ROS level, reducing the rate of cell death, and reducing cell apoptosis. In addition, in some literature and patents, ATA is not added to the culture medium in the form of a single component to play a role and solve the claimed technical problems. For example, in "Zhaolie Chen, et al. Biotechnology Letters 22:837-841, 2000", ATA is used as a chelating agent for transferrin and Fe 2+Adding them to the culture medium together promotes cell growth and changes the phenotype of cells. In "Hideo Miki, et al. Cytotechnology (2015) 67: 689-697", ATA is used as a substitute for IGF-1 and synergistically promotes cell growth with LPA. Patent document No. US5,045,454 discloses a serum-free growth medium, which selects a combination of iron chelates (including citrate / citric acid and Fe / EDTA), ATA and alkali metal EDTA as a substitute for transferrin in the culture medium. In other words, in this patent document, ATA is not added to the serum-free growth medium in the form of a single component to play a role, but requires the combination of iron chelates and alkali metal EDTA to solve the technical problems it claims. In addition, the patent document with publication number US6,338,964B1 discloses a culture medium suitable for culturing mammalian cells under conditions of low dissolved CO2 concentration, wherein the culture medium contains: an organic buffer with a concentration higher than 2mM, a metal complexing agent with a concentration higher than 5mM, and NaHCO3 with a concentration less than 1g / L, wherein the metal complexing agent is composed of histidine, iminodiacetic acid, citrate, phosphoserine, ATA and hydroxylysine. In the patents with publication numbers CN110894487A and CN111304149A, aurin tricarboxylic acid is also used as a substitute for insulin to stimulate the activation of insulin-like growth factor and promote cell utilization of glucose and amino acids. As can be seen from the above, the prior art is not clear about the effects of ATA or its salts itself on the growth, metabolism, especially lactic acid metabolism and production of mammalian cells. Moreover, there is no research report on the addition method and effect of ATA or its salts in the process of mammalian cell culture in the prior art. Summary of the invention
[0006] The culture medium is the most direct and important environmental factor for mammalian cell culture. The culture medium needs to support cell growth and also promote the synthesis and extracellular transport of target proteins. Suspension culture and serum-free culture have become the ideal mode of animal cell culture and the first choice for industrial production of animal cell expression products. In order to further improve the performance of CHO cells in serum-free culture medium, cell culture scientific research staff are committed to developing and evaluating the effects of various culture medium combinations including various additives on cell performance. The inventors found that, unexpectedly, not only additives such as ATA or its salts themselves but also the way they are added, such as the timing of addition, have a significant effect on cell performance and product expression. Based on the above findings, the inventors have provided an improved technical solution for mammalian cell culture after extensive and in-depth research and exploration.
[0007] In a first aspect, the present invention provides a method for culturing mammalian cells, the method comprising a seed culture stage and a production culture stage, wherein the seed culture stage is carried out in the presence of aurintricarboxylic acid or aurintricarboxylate salt for at least one generation starting from the next generation of seed recovery.
[0008] In a second aspect, the present invention provides a method for producing a target product using mammalian cells, comprising culturing mammalian cells according to the method of the present invention described above and harvesting the target product expressed by the cells.
[0009] In a third aspect, the present invention provides a method for improving lactic acid metabolism, cell growth and / or target product expression in mammalian cells, comprising culturing mammalian cells according to the method of the present invention described above. The improvement includes improving lactic acid metabolism, cell growth and / or target product expression in the production culture stage; and the improvement includes reducing lactic acid accumulation in the culture solution, increasing cell viability, increasing viable cell density and / or increasing the expression of the target product.
[0010] In a fourth aspect, the present invention provides the use of aurintricarboxylic acid or aurintricarboxylate salt applied to the seed culture stage to improve lactic acid metabolism, cell growth and / or target product expression during mammalian cell culture; wherein the improvement includes improvement of lactic acid metabolism, cell growth and / or target product expression in the production culture stage; and the improvement includes reducing lactic acid accumulation in the culture medium, increasing cell viability, increasing viable cell density and / or increasing the expression amount of the target product.
[0011] According to the present invention, the use of aurintricarboxylic acid or its salt as an additive to the basal culture medium in the seed culture stage can significantly improve the growth performance, byproduct metabolism and product expression of mammalian cells in the production culture stage. In particular, the method of the present invention significantly improves the cell viability and viable cell density of mammalian cells in the production culture stage, reduces lactic acid accumulation and enhances product expression. In addition, the ATA or its salt, such as ATA ammonium salt, used in the present invention is a single substance with a clear composition, which is easy to remove in the downstream purification process, has low cost, is easy to prepare and use, and can be used in combination with various commercial culture media or self-developed culture media. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] The drawings in the specification are used to assist in understanding the technical solutions, technical features and technical effects of the present invention. The drawings may be used to explain the claims but do not constitute a limitation on the scope of protection of the claims.
[0013] Figure 1 Schematic diagram of one embodiment of the mammalian cell culture method of the present invention. The embodiment includes a seed culture stage and a production culture stage, wherein the seed culture stage includes culture in the presence of ATA or ATA salt.
[0014] Figure 2-1 to Figure 2-4 The embodiment of the present invention shows the effect of adding ATA ammonium salt in the seed culture stage on the viable cell density and cell viability in the production culture stage. Figure 2-1 and Figure 2-2 Shows the effect of adding ATA ammonium salt in the last two generations of seed culture in Example 1; Figure 2-3 and Figure 2-4 In another example, the effect of culturing seed cultures in the presence of ATA ammonium salt from the next generation of revival is shown.
[0015] Figure 3 The effect of adding ATA ammonium salt in the seed culture stage on lactic acid metabolism in the production culture stage is shown in one embodiment of the present invention.
[0016] Figures 4-1 to 4-3 and Figures 4-4 to 4-6 The effects of optimizing the ATA ammonium salt concentration in the seed culture stage on the viable cell density, cell viability and lactic acid metabolism in the production culture stage in two culture processes in the embodiments of the present invention are respectively shown.
[0017] Figure 5-1 to Figure 5-6 The comparison of the effects of different addition times of ATA ammonium salt in one embodiment of the present invention is shown. Figure 5-1 to Figure 5-3 Comparison of live cell density, cell viability and lactate metabolism added at different times; Figure 5-4 to Figure 5-6 Shown is a comparison of ATA addition during the seed culture phase and ATA addition on day 0 of production culture. DETAILED DESCRIPTION
[0018] Herein, unless otherwise specified, “a” or “1” before a name, quantifier or unit indicates that there is at least one in number, thus encompassing a plural meaning.
[0019] Herein, unless otherwise specified, a numerical range expressed as two end values is deemed to specifically disclose the two end values and all real numbers between the two end values and the numerical range formed by the combination of two of them. In addition, unless otherwise specified, when multiple optional numerical ranges or values are specifically described for the same parameter, these end values and values can be arbitrarily combined, and the ranges obtained therefrom are all within the scope of the present invention as long as they are included in the maximum continuous range specifically described.
[0020] Herein, unless otherwise specified, the various technical features described herein, such as components, contents, steps, condition parameters, parameter values, assemblies, connection relationships, working relationships, etc., their combination methods are not limited to the various implementation methods and examples specifically described herein, and their other combinations also fall within the scope of the present invention.
[0021] Herein, unless otherwise specified, numerical values, whether or not accompanied by approximate expressions such as "approximately", "around", or "close", include the listed numerical values themselves and numerical values within a certain range of difference that can be understood by those skilled in the art to be equivalent thereto, such as values of ±25, ±20%, ±15%, ±10%, ±9%, ±8%, ±7%, ±6%, ±5%, ±4%, ±3%, ±2%, ±1% or smaller.
[0022] Herein, unless otherwise specified, the meanings of all scientific and technical terms are consistent with the well-known or known meanings in the art, especially in mammalian cell culture, genetic engineering and recombinant expression and production, such as those recorded in textbooks, experimental manuals or prior art documents. All patents and non-patent publications mentioned herein are incorporated herein by reference.
[0023] In a first aspect, the present invention provides a method for culturing mammalian cells, the method comprising a seed culture stage and a production culture stage, wherein at least one generation of culture from the next generation of seed recovery is carried out in the presence of ATA or an ATA salt.
[0024] Various culture media for culturing mammalian cells can be used in the method of the present invention. "Culture medium" refers to a liquid environment that is in direct contact with cells and on which cells depend for survival, including a collection of various nutrients and a buffer system. In some embodiments, the present invention uses a component culture medium (Chemical defined medium, CDM), that is, a culture medium with clear components. Preferably, the culture medium does not contain serum, animal-derived components (such as animal protein) and plant protein. Examples of animal proteins include but are not limited to bovine serum albumin (Bovine serum albumin, BSA), and examples of plant proteins include but are not limited to soy protein. In some embodiments, a culture medium that does not contain ATA or its salts is referred to as a "basal culture medium", including commercialized and independently developed culture media commonly used for mammalian cell culture, such as ActiPro basal culture medium (Hyclone) and CD CHO basal culture medium (Gibco).
[0025] Herein, "seed medium" refers to the medium used in the seed culture stage, that is, the medium used to culture seed cells before inoculation to production culture. "Production medium" refers to the medium used in the production culture stage, which is a medium used for cell growth, reproduction and production. Some production culture modes also use "feed medium", which refers to the culture medium added in a supplementary form during the cell culture process, used to supplement certain nutrients for cell culture. In the "inoculation of seed cells into production medium" and its synonymous expressions, the "production medium" here refers to the production medium that is already included in the bioreactor at the beginning of production culture, excluding feed medium. Preferably, these types of culture media are serum-free, animal protein-free and plant protein-free, and have clear composition, good batch-to-batch repeatability, and are easy to detect and analyze.
[0026] In this article, "seed culture", "seed culture stage" and "seed stage" are synonymous with each other, referring to the cell culture process from cell recovery to the start of production culture. It is a process of recovery, subculture, and step-by-step expansion of culture to finally obtain a certain number and quality of seed cells to be inoculated into the production medium for production. Seed culture can obtain the required inoculum amount, achieve cell adaptation and domestication, and is conducive to shortening the fermentation time in the production stage and ensuring the production level of the target product.
[0027] In the present invention, "production culture", "production culture stage" and "production stage" are synonymous with each other, and refer to the process of inoculating seed cells obtained from seed culture into the production medium in the bioreactor for culture until harvest. For the purpose of the present invention, production culture includes both culture for the purpose of harvesting the cell body itself, i.e., harvesting biomass, and culture for the purpose of harvesting the target product expressed by the cell. In some embodiments of the present invention, production culture adopts a batch feeding mode.
[0028] In some embodiments, the seed culture stage includes multiple generations. "N generation" refers to the formal production culture stage, "N-1 generation" refers to the generation of seeds before entering the production culture, that is, the last generation of seeds, that is, the seeds connected to the production tank, "N-2 generation" refers to the penultimate generation of seeds before entering the production culture, and so on. In some embodiments, the seed culture stage is passed on at least 4 times after the recovery culture. Herein, "the next generation of recovery" refers to the first generation after recovery. In some embodiments, at least the last two generations of the seed culture stage, namely the N-1 and N-2 generations, are cultured in the presence of ATA or ATA salts. In some embodiments, the cultivation of the seed culture stage from the next generation of seed recovery is carried out in the presence of ATA or ATA salts.
[0029] In some embodiments, the basal medium (i.e., medium without ATA or its salt) used in each generation of the seed culture stage may be the same or different. Examples of culture media include, for example, ActiPro basal medium and CD CHO basal medium. For example, in some embodiments, at least the last two generations of the seed stage are cultured in the presence of ATA or its salt using the same basal medium (e.g., ActiPro basal medium), while the basal medium before that may be different (e.g., CD CHO basal medium). In some embodiments, the basal medium used in at least the last generation or at least the last two generations is the same or similar to the production medium, for example, both are ActiPro basal medium, while the basal medium before that may be different.
[0030] In some embodiments, the content of ATA or ATA salt in the seed culture medium is at least about 0.025mM, preferably higher than 0.025mM. Suitable ranges include, for example, about 0.025-0.8mM, about 0.05-0.2mM, such as about 0.05mM, about 0.1mM, about 0.2mM, or about 0.6mM. In some embodiments, preferably about 0.05-0.1mM.
[0031] In the present invention, any ATA salt that can dissociate in the culture medium to form ATA ions can be used in the present invention. In some embodiments, the ATA salt is preferably an ATA ammonium salt, especially an ATA salt having a molecular formula of C 22 H 14 ATA ammonium salt of O9·3NH3 has the advantages of being easily soluble in water and convenient to prepare.
[0032] In some embodiments, the mammalian cell is a cell for recombinantly expressing the target product, also known as a host cell, which refers to a cell line derived from a mammal selected and domesticated according to production conditions for the production and preparation of biological preparations in the pharmaceutical industry. The post-translational modification of the protein expressed by the mammal has advantages in maintaining the biological activity, stability and antigenicity of the protein. Many cell lines are available from commercial sources, such as the American Type Culture Collection (ATCC). Non-limiting examples of mammalian cells that can be used in the present invention include CHO, BHK, HEK293 and other cells for the production of biological products. In some embodiments, the mammalian cell is a Chinese hamster ovary cell (CHO cell), such as a CHO-K1 cell. In some embodiments, such as in the following examples, the mammalian cell is a cell strain capable of stably expressing exogenous proteins constructed by transfecting CHO-K1 cells with a dual expression vector containing an exogenous coding gene.
[0033] In some embodiments, the target product is an exogenous protein, such as an Fc fusion protein, an antibody or an enzyme. "Exogenous protein" refers to a gene encoding a target protein outside the host cell within the scope of genetic engineering, which is effectively amplified and expressed by the host cell using DNA recombination technology to produce a protein with practical value. For example, Fc fusion proteins include but are not limited to IL-2 / Fc, GLP-1 / Fc, etc. Enzymes as target products include, for example, medicinal enzymes, such as but not limited to glucosidases, lipases, etc. In some embodiments, the target product is a monoclonal antibody, including but not limited to antibodies targeting tumor-specific antigens, tumor-associated antigens and / or autoimmune-related antigens, such as antibodies targeting CD19 / HER2, CD20, PD-1, LAG3, etc.
[0034] In a second aspect, the present invention provides a method for producing a target product using mammalian cells, comprising culturing cells using the method described in the first aspect above and harvesting the target product expressed by the cells.
[0035] In a third aspect, the present invention provides a method for improving mammalian cell lactate metabolism, cell growth and / or target product expression, comprising culturing cells using the method described in the first aspect above.
[0036] In a fourth aspect, the present invention provides the use of aurintricarboxylic acid or aurintricarboxylate salts applied to the seed culture stage to improve lactate metabolism, cell growth and / or target product expression during mammalian cell culture.
[0037] The methods and uses described in the above aspects of the present invention provide the effect of improving mammalian cell lactate metabolism, cell growth and / or target product expression. In particular, the improvement includes improvement of lactate metabolism, cell growth and / or target product expression in the production culture stage. Wherein, the improvement of lactate metabolism is manifested as reducing lactate accumulation in the culture fluid. Wherein, the cell growth condition can be characterized by viable cell density and / or cell viability. Therefore, the improvement includes reducing lactate accumulation in the culture fluid, increasing cell viability, increasing viable cell density and / or increasing the expression of the target product. The improvement can be determined by comparison with a control, and the control can be a culture process in which the only difference is that ATA or its salt is not added in the seed culture stage, or a culture process in which the only difference is that ATA or its salt is not added in the seed culture stage, for example, it is added in the production stage instead of the seed stage.
[0038] Example
[0039] The technical scheme of the present invention will be described in more detail below in conjunction with specific embodiments. The following embodiments are only examples and do not constitute any limitation or restriction on the technical scheme of the present invention. The specific materials, steps, conditions, values or numerical ranges and other technical parameters in the following embodiments are only examples and are not exhaustive or limiting.
[0040] The cells used in the following examples are cell lines capable of stably expressing IgG1 monoclonal antibody, IgG4 monoclonal antibody or Fc fusion protein, constructed by transfecting CHO-K1 model cells with dual expression vectors containing genes encoding IgG1, IgG4 or Fc fusion protein.
[0041] The culture media and culture medium supplements used in the following examples are all commercially available: ActiPro basal medium (Hyclone, Cat No.: SH31037); CD CHO basal medium (Gibco, Cat No.: 12490); Cell Boost 7a feed medium (HyClone, Cat No.: SH31026); Cell Boost 7b feed medium (HyClone, Cat No.: SH31027); ATA (Sigma, Cat. No: A1895), ATA ammonium salt (Sigma, Cat. No: A36883).
[0042] Example 1: Preparation of a culture medium containing aurintricarboxylic acid or aurintricarboxylic acid ammonium salt
[0043] 1.1 Preparation method of aurintricarboxylic acid or aurintricarboxylic acid ammonium salt storage solution
[0044] Water for injection (WFI) was selected to prepare all solutions. The composition of 100× stock solution is shown in Table 1.
[0045] The preparation method of the stock solution described in Table 1 is as follows:
[0046] Step 1) Select a container of appropriate size to hold water for injection of the quality described in Table 1;
[0047] Step 2) Adding ATA or ATA ammonium salt powder of the mass described in Table 1 into the container described in step 1);
[0048] Step 3) ATA needs to be dissolved under alkaline conditions: add an appropriate amount of 10N NaOH to adjust the pH to 12.2±0.2, and mix evenly at room temperature; ATA ammonium salt can be dissolved in water at room temperature. After it is fully dissolved, add water for injection to the final mass and mix evenly again;
[0049] Step 4) filtering the solution using a filter membrane with a pore size of 0.1 μm or 0.2 μm;
[0050] Step 5) Store at 4-8°C.
[0051] Table 1: Composition of 20 mM ATA and ATA ammonium salt stock solutions (1.0 kg)
[0052]
[0053] #1: The amount of water for injection is the initial amount added, and the final amount of water for injection added is not shown.
[0054] 1.2 Preparation method of culture medium containing aurintricarboxylic acid or aurintricarboxylic acid ammonium salt for cell culture
[0055] 1) Preheat the stock solution described in Section 1.1 of this Example to 37°C;
[0056] 2) Take a certain volume of the preheated storage solution and add it to the ActiPro basal medium or CD CHO basal medium, and mix them evenly to obtain a medium containing a specific concentration of ATA or ATA ammonium salt.
[0057] Example 2: Effect of adding aurin tricarboxylate ammonium salt in the seed culture stage on cell growth in the production culture stage
[0058] "N generation" refers to the formal production and cultivation stage, "N-1 generation" refers to the generation before seeds enter production and cultivation, and "N-2 generation" refers to the penultimate generation before seeds enter production and cultivation.
[0059] 2.1: The last two generations of seed culture were cultured in the presence of aurin tricarboxylate ammonium salt
[0060] The following groups were set up: (1) control group (Ctrl), i.e., no ATA ammonium salt was added to the seed culture; (2) ATA ammonium salt group, i.e., 0.05 mM ATA ammonium salt was added to the seed culture at the N-2 and N-1 generations.
[0061] Use CDCHO medium as the medium for seed culture N-3 and earlier generations, and ActiPro basal medium as the basal medium for seed culture N-2, N-1 generations and production culture.
[0062] Seed cell culture and adaptation: The seed cells are CHO-K1 cells that stably express IgG1 protein A. The frozen seed cells were taken out from the liquid nitrogen tank for revival and the culture medium was about 0.45×10 6 The initial inoculation density was 10 cells / mL and the cells were revived in a 125 mL shake flask filled with 30 mL of CD CHO medium. Thereafter, the seed suspension was inoculated at a density of approximately 0.25 × 106 The N-4 and N-3 generations of seed culture were restored in 250 mL shake flasks filled with 50 mL CDCHO at an initial inoculation density of 10 cells / mL. The seed suspension was inoculated at a density of approximately 0.25 × 10 6 The N-2 and N-1 generation seeds were adapted to the culture in a 250 mL shake flask with 50 mL of culture medium at an initial inoculation density of 10 cells / mL; the "control group" used ActiPro basal medium without ATA ammonium salt, and the "ATA ammonium salt group" added 0.05 mM ATA ammonium salt to ActiPro basal medium. Seed subculture and expansion were carried out in a shaker, and the shaker conditions were set as follows: temperature 36.5 ° C, speed 125 rpm, 6% CO2 and 80% humidity.
[0063] Fed-batch culture was used for production culture: N-1 generation seed cells in the logarithmic growth phase were cultured at a rate of 0.40×10 6 The cells were inoculated into 250 mL shake flasks containing 50 mL ActiPro basal medium at an initial density of 10 cells / mL, with a culture volume of 50 mL, and cultured in a shaker at 36.5°C, 125 rpm, 6% CO2 and 80% humidity. On the 4th day, the culture was moved to a shaker at 33.0°C, 125 rpm, 6% CO2 and 80% humidity. Feeds were performed on the 3rd, 5th, 7th, 8th and 9th days, with feed ratios of 4%, 3%, 3%, 3%, 1% CB7a and 0.4%, 0.3%, 0.3%, 0.3%, 0.1% CB7b, respectively. Feed ratio = feed volume / initial culture volume.
[0064] During the production and cultivation process, the live cell density and cell viability are monitored to characterize the cell growth. The live cells and cell viability are determined using Beckman's Vi-Cell based on the trypan blue staining principle.
[0065] Results: Figure 2-1 and 2-2 As shown, compared with the control group, the addition of ATA ammonium salt in seed culture N-2 and N-1 generations significantly increased the cell viability in the production culture stage and was able to maintain the viable cell density for a longer period of time.
[0066] 2.2: Seed culture stage: From the next generation of recovery, culture is carried out in the presence of aurin tricarboxylic acid ammonium salt
[0067] The model cell CHO-K1 stably expressing Fc fusion protein was used for seed culture, production culture, and monitoring of live cell density and cell viability in accordance with Example 2.1. The "control group" and "ATA ammonium salt group" were still set up, but the difference was that 0.01mM ATA ammonium salt was added to the CDCHO medium used in the N-4 and N-3 generations and the ActiPro basal medium used in the N-2 and N-1 generations in the "ATA ammonium salt group". The feeding scheme was: 3%, 4%, 4%, 3%, 3%, 1% CB7a and 0.3%, 0.4%, 0.4%, 0.3%, 0.3%, 0.1% CB7b were added on the 3rd day, the 5th day, the 7th day, the 9th day, the 11th day and the 13th day, respectively. Feed ratio = feed volume / initial culture volume.
[0068] Results: Figure 2-3 and 2-4 As shown, compared with the control group, culturing the seed culture in the presence of ATA ammonium salt from the next generation of resuscitation significantly improved the cell viability, viability maintenance and viable cell density in the production culture stage.
[0069] Example 3: Effect of adding aurin tricarboxylate ammonium salt in the seed culture stage on lactic acid metabolism in the production culture stage
[0070] As described in Example 2.1, seed culture and production culture were performed using CHO-K1 model cells expressing IgG1 protein A. The following groups were set up: (1) control group (Ctrl), i.e., seed culture without the addition of ATA ammonium salt; (2) ATA ammonium salt group, i.e., seed culture N-2 and N-1 generations with the addition of 0.05 mM ATA ammonium salt.
[0071] During the production culture stage, the lactate concentration was measured using the Cedex Bio HT Analyzer from Life Technologies based on the lactate oxidase method.
[0072] Results: Figure 3 As shown, adding ATA ammonium salt to seed culture can effectively solve the problem of lactic acid accumulation during cell metabolism in the production culture stage.
[0073] Example 4: Optimization of the concentration of aurin tricarboxylate ammonium salt during the seed culture stage
[0074] 4.1: Experiments using the CHO-K1 model cell line expressing IgG1 protein A
[0075] The following groups were set up: (1) Control group (Ctrl): no ATA ammonium salt was added to the seed culture; (2) 0.025 mM ATA ammonium salt group: 0.025 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (3) 0.05 mM ATA ammonium salt group: 0.05 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (4) 0.1 mM ATA ammonium salt group: 0.1 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (5) 0.2 mM ATA ammonium salt group: 0.2 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations.
[0076] As described in Example 2.1, seed culture, production culture, and monitoring of viable cell density and cell viability were performed using model cells CHO-K1 expressing IgG1 protein A. Lactic acid concentration was measured as described in Example 3. Antibody expression was measured using the Cedex Bio HT Analyzer from Life Technologies based on the immunoturbidimetric method.
[0077] Effect on cell growth during production and culture
[0078] like Figure 4-1 and 4-2 As shown, compared with the control group, the addition of 0.025-0.2 mM ATA ammonium salt to seed culture had no significant effect on the growth of cells in the early stage of production culture. However, it is worth noting that in the later stage, the live cell density and viability of the control group dropped to almost 0 at the time of harvest, while the group adding 0.05-0.2 mM ATA ammonium salt was able to significantly maintain the cell viability and live cell density in the later stage of culture.
[0079] Effects on lactate metabolism during the production and cultivation phase
[0080] like Figure 4-3 As shown, adding 0.05-0.2 mM ATA ammonium salt to seed culture can effectively reduce lactic acid accumulation during the culture process.
[0081] Effect on product expression
[0082] As shown in Table 2 below, adding 0.025-0.2 mM concentration of ATA ammonium salt to seed culture can increase the antibody expression level, and 0.05-0.2 mM is more significant.
[0083] Table 2: ATA ammonium salt concentration in seed culture and antibody expression
[0084]
[0085]
[0086] The above results show that 0.05-0.2 mM ATA ammonium salt is the preferred addition concentration. Considering the material cost and minimizing the residual additives in the biopharmaceutical preparation, 0.05 mM ATA ammonium salt can be used as the most preferred addition concentration.
[0087] 4.2: Experiments with CHO-K1 cell line expressing IgG1 protein B
[0088] The following groups were set up: (1) Control group (Ctrl): no ATA ammonium salt was added to the seed culture; (2) 0.1 mM ATA ammonium salt group: 0.1 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (3) 0.2 mM ATA ammonium salt group: 0.2 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (4) 0.6 mM ATA ammonium salt group: 0.6 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations; (5) 0.8 mM ATA ammonium salt group: 0.8 mM ATA ammonium salt was added to the seed culture N-2 and N-1 generations.
[0089] As described in Example 2.1, the model cell CHO-K1 stably expressing IgG1 protein B was used for seed culture, production culture, and monitoring of live cell density and cell viability. The difference is that the feeding scheme is: 3%, 3%, 3%, 3%, 2% CB7a and 0.3%, 0.3%, 0.3%, 0.3%, 0.2% CB7b were added on the 3rd, 5th, 7th, 10th and 12th days, respectively. Feed ratio = feed volume / initial culture volume. Lactic acid concentration was detected as described in Example 3. The antibody expression level was determined using the Cedex Bio HT Analyzer of Life Technologies based on the immunoturbidimetric method.
[0090] Effect on cell growth during production and culture
[0091] like Figure 4-4 and 4-5 As shown, compared with the control group, the addition of 0.1-0.8 mM ATA ammonium salt to seed culture can significantly maintain cell viability and viable cell density in the later stage of culture. The addition of 0.6 and 0.8 mM ATA ammonium salt groups can maintain a higher harvest viability.
[0092] Effects on lactate metabolism during the production and cultivation phase
[0093] like Figure 4-6 As shown, the addition of 0.1-0.8 mM ATA ammonium salt to seed culture can significantly inhibit the accumulation of lactic acid in the late culture period. The lactic acid concentration in the groups with 0.1 and 0.2 mM ATA ammonium salt was the lowest.
[0094] Effect on product expression
[0095] As shown in Table 3 below, adding 0.1-0.2 mM concentration of ATA ammonium salt to seed culture can increase the antibody expression level, and 0.1 mM has the most significant effect.
[0096] Table 3: ATA ammonium salt concentration in seed culture and antibody expression
[0097]
[0098] The above results show that 0.1 mM ATA ammonium salt can also be used as the most preferred addition concentration.
[0099] Example 5: Comparison of the timing of adding aurin tricarboxylic acid ammonium salt
[0100] 5.1 Comparison between multiple time points
[0101] The following groups were set up: (1) control group (Ctrl), i.e., no ATA ammonium salt was added to seed culture and production culture; (2) group with 0.05 mM ATA ammonium salt added to N-2 and N-1 generations, i.e., 0.05 mM ATA ammonium salt was added to seeds N-2 and N-1 generations, but no ATA ammonium salt was added to production culture; (3) group with 0.1 mM ATA ammonium salt added to N-2 and N-1 generations, i.e., 0.1 mM ATA ammonium salt was added to seeds N-2 and N-1 generations, but no ATA ammonium salt was added to production culture; (4) group with 0.05 mM ATA ammonium salt added on day 0 of production culture, i.e., no ATA ammonium salt was added to seed culture, but 0.05 mM ATA ammonium salt was added on day 0 after inoculation into production culture medium; (5) group with 0.1 mM ATA ammonium salt added on day 4 of production culture, i.e., no ATA ammonium salt was added to seed culture, but 0.1 mM ATA ammonium salt was added on day 4 after inoculation into production culture medium.
[0102] As described in Example 2.1, seed culture, production culture, and monitoring of viable cell density and cell viability were performed using CHO-K1 expressing IgG1 protein A. Lactic acid concentration was measured as described in Example 3. Antibody expression was determined as described in Example 4.
[0103] Effect on cell growth during production and culture
[0104] like Figure 5-1 and 5-2 As shown, compared with the control group, the addition of ATA ammonium salt in seed culture and on day 0 of production culture could effectively maintain cell viability, but the viability of the group adding ATA ammonium salt in the middle of production culture (the fourth day) could not be maintained.
[0105] Effects on lactate metabolism during the production and cultivation phase
[0106] like Figure 5-3 As shown, adding ATA ammonium salt during seed culture and adding ATA ammonium salt on day 0 of production culture can effectively reduce lactic acid accumulation during the culture process.
[0107] Effect on product expression
[0108] As shown in Table 4 below, compared with other groups, the addition of ATA ammonium salt to seed culture can effectively increase the antibody expression level, and its expression level is the highest, which is not only significantly higher than the control but also significantly higher than the addition of ATA ammonium salt on day 0 of production culture.
[0109] Table 4: Different ATA ammonium salt addition time and antibody expression level
[0110]
[0111] Based on the above results, adding ATA ammonium salt in the seed culture stage and on the 0th day of production culture can significantly increase cell viability, improve lactic acid metabolism and increase antibody expression. However, it is worth noting that the antibody expression level of adding ATA ammonium salt in the seed culture stage is higher than that of adding it on the 0th day of production culture, which has significant practical significance for the production of biopharmaceuticals.
[0112] 5.2 Comparison of adding ATA ammonium salt during seed culture and adding ATA ammonium salt on day 0 of production culture
[0113] The following groups were set up: (1) 0.1 mM ATA ammonium salt was added to the N-2 and N-1 generations, that is, 0.1 mM ATA ammonium salt was added to the seeds at the N-2 and N-1 generations, and no ATA ammonium salt was added to the production culture; (2) 0.1 mM ATA ammonium salt was added on the 0th day of production culture, that is, no ATA ammonium salt was added to the seed culture, and 0.1 mM ATA ammonium salt was added on the 0th day of production culture.
[0114] Seed cell culture and adaptation: The seed cells are CHO-K1 cells that stably express IgG4. The frozen seed cells were taken out from the liquid nitrogen tank and revived. 6 The seed suspension was revived in a 125 mL shake flask containing 30 mL of CDCHO medium at an initial inoculation density of about 10 cells / mL. 6 The N-4 and N-3 generations of seed culture were restored in 250 mL shake flasks containing 50 mL of CDCH2O at an initial inoculation density of 10 cells / mL. The seed suspension was inoculated at a density of approximately 0.50 × 10 6The N-2 and N-1 generations were adapted and expanded in 250 mL shake flasks with 50 mL ActiPro basal medium at an initial inoculation density of 10 cells / mL; the ActiPro basal medium used in N-2 and N-1 both contained 0.10 mM ATA ammonium salt, while the "0.1 mM ATA ammonium salt added on day 0 of production culture group" did not. Seed subculture was carried out in a shaker, and the shaker conditions were set as follows: temperature 36.5 ° C, speed 125 rpm, 6% CO2 and 80% humidity.
[0115] Fed-batch culture was used for production culture: N-1 generation seed cells in the logarithmic growth phase were cultured at a rate of 1.00×10 6 The cells were inoculated into a 250 mL shake flask containing 50 mL ActiPro basal medium at an initial density of 10 cells / mL, and the culture volume was 50 mL. The cells were cultured in a shaker at 36.5°C, 125 rpm, 6% CO2 and 80% humidity, and moved to a shaker at 33.0°C, 125 rpm, 6% CO2 and 80% humidity on the 4th day. For the "0.1 mM ATA ammonium salt added on day 0 of production culture group", 0.1 mM ATA ammonium salt was added on day 0, and no ATA ammonium salt was added in the "0.1 mM ATA ammonium salt added group of N-2 and N-1 passages". The feeding scheme was: 2% CB7a and 0.2% CB7b were added on days 2-6, 8 and 12, respectively, and 3% CB7a and 0.3% CB7b were added on days 7 and 9-11. Feed ratio = feed volume / initial culture volume.
[0116] The viable cell density and cell viability were monitored as described in Example 2.1. The lactic acid concentration was detected as described in Example 3. The antibody expression level was determined as described in Example 4.
[0117] Effect on cell growth during production and culture
[0118] like Figure 5-4 and 5-5 As shown, compared with the addition of ATA ammonium salt on day 0 of production culture, the addition of ATA ammonium salt to seed culture increased the viable cell density of production culture and had a significant cell growth advantage.
[0119] Effects on lactate metabolism during the production and cultivation phase
[0120] like Figure 5-6 As shown, compared with the addition of ATA ammonium salt on day 0 of production culture, the overall lactate concentration during the production culture stage of seed culture supplemented with ATA ammonium salt was significantly reduced.
[0121] Effect on product expression
[0122] As shown in Table 5 below, compared with the addition of ATA ammonium salt on day 0 (D0) of production culture, the addition of ATA ammonium salt to seed culture effectively increased the antibody expression level by about 30%.
[0123] Table 5: Antibody expression levels after ATA addition in seed culture and D0 of production culture
[0124]
[0125] Based on the above results, the most preferred time to add ATA ammonium salt is the seed culture stage. Even compared with adding it at the beginning of production culture or even on day 0, adding it during seed culture can significantly increase the density of living cells and enhance the expression of antibodies, which has important practical significance for the production of biopharmaceuticals.
[0126] The specific embodiments of the present invention are described in detail above, but they are only examples. The present invention is not limited to the specific embodiments described above. The scope of the present invention covers all equivalent modifications and substitutions that are consistent with the concept and purpose of the present invention.
Claims
1. A method for culturing mammalian cells, the method comprising a seed culture stage and a production culture stage, wherein the seed culture stage is carried out in the presence of aurintricarboxylic acid or aurintricarboxylate from the next generation of seed recovery, wherein the mammalian cells are CHO cells, the N-1 generation refers to the generation of the seeds before entering production culture, and in the seed culture stage, when aurintricarboxylic acid or aurintricarboxylate is present, its content in the culture medium is 0.05-0.2 mM.
2. The method according to claim 1, wherein the culture of at least the last two generations in the seed culture stage is carried out in the presence of aurintricarboxylic acid or aurintricarboxylate; or, the culture of the seed culture stage starting from the next generation of seed revival is carried out in the presence of aurintricarboxylic acid or aurintricarboxylate.
3. The method according to claim 1 or 2, wherein the aurintricarboxylate is aurintricarboxylate ammonium salt.
4. The method of claim 1, wherein the mammalian cells recombinantly express the target product.
5. The method according to claim 4, wherein the target product is an exogenous protein or a monoclonal antibody.
6. A method for producing a target product using mammalian cells, comprising culturing mammalian cells using the method of any one of claims 1 to 5 and harvesting the target product expressed by the cells.
7. A method for improving lactic acid metabolism, cell growth and / or target product expression in mammalian cells, comprising culturing mammalian cells using the method of any one of claims 1 to 5; wherein: The improvements include improvements in lactic acid metabolism, cell growth and / or target product expression during the production culture phase; and the improvements include reducing lactic acid accumulation in the culture medium, increasing cell viability, increasing viable cell density and / or increasing the target product expression level.
8. Use of aurintricarboxylic acid or aurintricarboxylate salts in the seed culture stage to improve lactic acid metabolism, cell growth and / or target product expression of mammalian cells during culture; wherein, The improvement includes the improvement of lactic acid metabolism, cell growth and / or target product expression in the production culture stage; and the improvement includes reducing lactic acid accumulation in the culture medium, increasing cell viability, increasing viable cell density and / or increasing the expression amount of the target product, the seed culture stage is carried out in the presence of aurintricarboxylic acid or aurintricarboxylate from the next generation of seed recovery, the mammalian cell is a CHO cell, the N-1 generation refers to the generation of seeds before entering the production culture, and in the seed culture stage, when aurintricarboxylic acid or aurintricarboxylate is present, its content in the culture medium is 0.05-0.2mM.
9. The use according to claim 8, wherein The aurintricarboxylate is aurintricarboxylate ammonium salt.
